Table 1 Demographic characteristics at baseline in the total vaccinated cohorts
TIV | QIV | |||
|---|---|---|---|---|
N = 120 | N = 112 | |||
18–60 years | >60 years | 18–60 years | >60 years | |
n = 50 | n = 70 | n = 56 | n = 56 | |
Mean age, years (SD; median; range) | 34.8 | 66.6 | 40.9 | 68.6 |
(13.72; 28.0; 19.0–59.0) | (4.73; 65.0; 61.0–81.0) | (13.33; 39.5; 22.0–60.0) | (4.72; 67.5; 61.0–82.0) | |
Male, n (%) | 17 (34.0) | 31 (44.3) | 22 (39.3) | 26 (46.4) |
Female, n (%) | 33 (66.0) | 39 (55.7) | 34 (60.7) | 30 (53.6) |
Ethnic origin, n (%) | ||||
White Caucasian/European heritage | 47 (94.0) | 69 (98.6) | 54 (96.4) | 56 (100) |
Other | 3 (6.0) | 1 (1.4) | 2 (3.6) | 0 |
Seasonal influenza in at least 1 season from previous 3 seasons | 20 (40.0) | 44 (62.9) | 54 (96.4) | 54 (96.4) |
AS03-adjuvanted pandemic influenza vaccine in the previous (2010–2009) season | 26 (52.0) | 33 (47.1) | n/a | n/a |